checkAd

Novavax - Vergessene Aktie feiert ein Comeback. Gute Chancen dank aktueller Nachrichtenlage (Seite 168)

eröffnet am 25.04.09 09:22:26 von
neuester Beitrag 06.04.21 16:03:46 von


Beitrag schreiben

Begriffe und/oder Benutzer

 

Fragen

 Ja Nein
Avatar
04.02.21 22:06:06
Beitrag Nr. 1.671 ()
Poland to have two new vaccine suppliers from 2nd quarter
FEBRUARY 01, 2021

Poland plans to sign contracts with two new vaccines suppliers, Novavax and Johnson&Johnson, in the second quarter of this year, the health minister said on Monday.
...
"In the second quarter we are expecting at least one decision concerning the Novavax company, and another on Johnson&Johnson,” Niedzielski said. “This means two more suppliers."
...
https://www.thefirstnews.com/article/poland-to-have-two-new-…
Novavax | 280,60 $
Avatar
04.02.21 22:15:52
Beitrag Nr. 1.672 ()
Novavax Announces Start of Rolling Review by Multiple Regulatory Authorities for COVID-19 Vaccine Authorization
Feb 04, 2021 at 4:05 PM EST

GAITHERSBURG, Md., Feb. 04, 2021 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the start of the rolling review process for authorization of NVX-CoV2373, its COVID-19 vaccine, by multiple regulatory agencies. The reviews will continue while the company completes its pivotal Phase 3 trials in the United Kingdom (U.K.) and United States (U.S.) and through initial authorization for emergency use granted under country-specific regulations.

“The rolling review of our submission by regulatory authorities of non-clinical data and early clinical studies will help expedite the review process and bring us that much closer to delivering a safe and effective vaccine worldwide,” said Gregory M. Glenn, MD, President of Research and Development, Novavax. “We appreciate the agencies’ confidence in Novavax based on our early data and the collective sense of urgency to ensure speedier access to much-needed COVID-19 vaccination.”

To date, Novavax has begun the rolling review process with several regulatory agencies worldwide, including the European Medicines Agency (EMA), U.S. Food and Drug Administration (FDA), U.K. Medicines and Healthcare products Regulatory Agency (MHRA), and Health Canada. As part of the rolling review, the company will continue to submit additional information, including clinical and manufacturing data.

Novavax’ recombinant protein-based vaccine candidate is currently in Phase 3 clinical development in both the U.K. and U.S. for the prevention of COVID-19. It was the first vaccine to demonstrate clinical efficacy against the original strain of COVID-19 and both of the rapidly emerging variants in the United Kingdom and South Africa.

https://ir.novavax.com/news-releases/news-release-details/no…
Novavax | 235,10 €
Avatar
11.02.21 12:51:08
Beitrag Nr. 1.673 ()
EU close to sealing supply deal with Novavax for COVID-19 vaccines
FEBRUARY 11, 2021 11:11 AM

BRUSSELS (Reuters) - The European Union could sign a supply deal with Novavax this week or next for the U.S. company’s COVID-19 vaccine candidate, two EU officials involved in the talks with the firm said.

The EU concluded in December preliminary negotiations with Novavax for the supply of 100 million doses and an option for another 100 million.

“Talks with Novavax have intensified and we aim to agree the contract this week or next,” one EU official said.

https://www.reuters.com/article/idUSL1N2KH0Q1
Novavax | 246,05 €
1 Antwort
Avatar
11.02.21 14:07:29
Beitrag Nr. 1.674 ()
Die Einschreibung für die US Studie scheint beendet worden zu sein

"This trial has completed recruitment on this platform, and is no longer accepting new referrals."
https://www.novavax.com/PREVENT-19?utm_source=nvax&utm_mediu…
Novavax | 250,70 €
Avatar
18.02.21 22:21:06
Beitrag Nr. 1.675 ()
Novavax Announces Memorandum of Understanding with Gavi for Cumulative Supply to COVAX Facility of 1.1 Billion Doses of COVID-19 Vaccine
Feb 18, 2021 at 4:02 PM EST

- Advances joint commitment from Novavax, Serum Institute of India and Gavi to ensure equitable access to NVX-CoV2373 worldwide across low-, middle- and high-income countries

-Memorandum of understanding (MOU) between Gavi and Novavax to make available a cumulative volume of 1.1 billion doses of the Novavax vaccine to the COVAX Facility
https://ir.novavax.com/news-releases/news-release-details/no…
Novavax | 220,00 €
Avatar
18.02.21 22:49:55
Beitrag Nr. 1.676 ()
Antwort auf Beitrag Nr.: 66.951.620 von DasTier666 am 11.02.21 12:51:08
Zitat von DasTier666: EU close to sealing supply deal with Novavax for COVID-19 vaccines
FEBRUARY 11, 2021 11:11 AM

BRUSSELS (Reuters) - The European Union could sign a supply deal with Novavax this week or next for the U.S. company’s COVID-19 vaccine candidate, two EU officials involved in the talks with the firm said.

The EU concluded in December preliminary negotiations with Novavax for the supply of 100 million doses and an option for another 100 million.

“Talks with Novavax have intensified and we aim to agree the contract this week or next,” one EU official said.

https://www.reuters.com/article/idUSL1N2KH0Q1


Das Zeitfenster schließt sich bald. Ich gespannt, ob da noch was kommt :look:
Novavax | 220,00 €
Avatar
22.02.21 09:11:12
Beitrag Nr. 1.677 ()
Ich denke, dass für Polen und andere EU Länder der Impfstoff von Novavax kommen wird. Die letzten werden die ersten sein (Novavax mit neuem Impfstoff, Sputnik - neuer Imofstoff! von den Russen, Algernon mit seinem neuen Cornamedikament, usw).
Novavax | 227,20 €
Avatar
23.02.21 09:53:40
Beitrag Nr. 1.678 ()
Die Monatskerze sieht ja bis jetzt nicht gerade erbaulich aus!Da muss noch die letzten Tage was positives geschehen.
Novavax | 194,22 €
Avatar
02.03.21 16:17:34
Beitrag Nr. 1.679 ()
Novavax stellt US-Antrag auf vorz. Bewilligung
ihres Covid-19 Impfstoffes, auf Grund der GB und Südafrikanischen Bewilligungen. Novavax hat Vergträge zur Auslieferung von xxx-Millionen Dosen pro Land, könnten sofort ausgeliefert werden. Ist für mich zumindest eine sehr gute News.

Aber natürlich, so wie im Sport, wer hoch hinaus will, der muss zuerst nach untern einen grossen Anlauf nehmen um möglichst hoch zu springen, und Börse ist genau so und nicht anders. Dazu sorgen auch die Shorter bei allen Titeln. Ist doch verständlich, bei Topmeldung erstmal bashen, weil ein günstiger Einkauf ist gut verständlich erwünscht.

😎 Ich behalte natürlich jetzt alle, weil langfristig investiert. Mit Gewinnsicherungen habe ich den Einsatz schon doppelt rausbekommen.

https://finance.yahoo.com/news/novavax-ceo-if-fda-waits-for-…

🤠
Novavax | 217,21 $
Avatar
02.03.21 16:29:20
Beitrag Nr. 1.680 ()
So ein Blödsinn, Verlust habe sich erhöht?.

Wirtschaftlichkeit wenig Ahnung wer so was schreibt, denn um Billionen Covid-Dosen herzustellen, braucht es erst mal enorme Investitionen, nämlich bevor dann erst Milliarden von US-$ herein geschwemmt werden.

Die Frage ist, bekommt Vavarax die Auslieferungsgenehmigung der USA.

Ich sage JA, bestimmt.

🤠
Novavax | 219,96 $
 Durchsuchen


Beitrag zu dieser Diskussion schreiben

Novavax - Vergessene Aktie feiert ein Comeback. Gute Chancen dank aktueller Nachrichtenlage